首页> 外文会议>International Workshop on Multimodal Brain Image Analysis >Prioritizing Amyloid Imaging Biomarkers in Alzheimer's Disease via Learning to Rank
【24h】

Prioritizing Amyloid Imaging Biomarkers in Alzheimer's Disease via Learning to Rank

机译:通过学习排名,在阿尔茨海默病中优先考虑淀粉样蛋白成像生物标志物

获取原文

摘要

We propose an innovative machine learning paradigm enabling precision medicine for AD biomarker discovery. The paradigm tailors the imaging biomarker discovery process to individual characteristics of a given patient. We implement this paradigm using a newly developed learning-to-rank method PLTR. The PLTR model seamlessly integrates two objectives for joint optimization: pushing up relevant biomarkers and ranking among relevant biomarkers. The empirical study of PLTR conducted on the ADNI data yields promising results to identify and prioritize individual-specific amyloid imaging biomarkers based on the individual's structural MRI data. The resulting top ranked imaging biomarker has the potential to aid personalized diagnosis and disease subtyping.
机译:我们提出了一种创新机器学习范式,可实现AD Biomarker发现的精确药物。范例裁定成像生物标志物发现过程,以给定患者的个体特征。我们使用新开发的学习 - 排名方法PLTR来实现此范例。 PLTR模型无缝地整合两个联合优化目标:推动相关的生物标志物并在相关的生物标志物中排名。对ADNI数据进行的PLTR的实证研究产生了有希望基于个体的结构MRI数据识别和优先考虑单个特异性淀粉样成像生物标志物。得到的顶部排名成像生物标志物有可能有助于辅助个性化诊断和疾病亚型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号